24th Nov 2005 14:00
Advanced Medical Solutions Grp PLC24 November 2005 Advanced Medical Solutions Group plc ("AMS" or "the Company") AMS value range reduces NHS spend on woundcare Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces that a clinical evaluationpresented at the recent Wounds UK meeting in Harrogate has demonstrated theability of AMS' ActivHeal(R) range of basic advanced woundcare products todeliver immediate savings to the NHS. The study was carried out by several Tissue Viability Nurses at St. JohnsHospital, West Lothian Healthcare NHS Trust, in two medical wards over a fourweek period to provide feedback to Scottish Healthcare Supplies on how theproducts work in clinical practice. The study compared the ActivHeal(R) rangewith branded products already in use within the Trust. The ActivHeal(R) rangeperformed equally or better than the branded products in all cases over a rangeof wounds covering pressure ulcers, pre-tibial lacerations and graft donorsites. There were no problems recorded with any of the products in use. A costbenefit study carried out following St. Johns Hospital's changing to theActivHeal(R) range in August 2005 has shown a significant cost saving in the useof the ActivHeal(R) products. It was concluded in the reported study that the products evaluated within theActivHeal(R) range have allowed the cost of treating wounds within West Lothianto be reduced whilst still maintaining the quality of woundcare. Commenting Dr. Don Evans, Chief Executive of AMS, said: "This study clearly confirms the opportunity offered to the NHS by theintroduction of the ActivHeal(R) value range of wound dressings. More and morehospitals are reaching the same conclusion that these products can offerconsiderable savings - typically saving up to 40% of their advanced woundcarebudget - without any compromise to patient care. Based on current spends withinEngland and Scotland, there is an immediate saving of the order of £25mavailable to the NHS at a time of severe funding pressure." -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel: +44 (0)1606 545508 Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group